Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool

Sectra and RSA Biomedical are partnering to distribute a tool to measure and validate orthopedic implant movement for improved patient safety. The contract calls for RSA Biomedical to offer the Sectra CT-based Micromotion Analysis (Sectra CTMA).

The Sectra CTMA helps facilitate the measurement of movements between implants and bone using computed tomography images (CT images). The method uses CT images taken typically up to two years after implantation to measure the 3D movement of an implant or bone fragment on a submillimeter scale. With this data, scientists can analyze the movement of an implant or bone segment over time. This early high-precision information provides a strong predictor of the long-term survival of the implant.     
 
“For the past two decades, we have supported orthopedists and implant manufacturers by providing measurement methods for validating implants and our brand is market leading in terms of quality. Sectra’s CT-based measurement method represents a paradigm shift in this field as it contains clear advantages for patients, surgeons and the implant industry. We are excited about the opportunity to help bring this emerging technology to the market,” said Per Grundström, president and CEO of RSA Biomedical. 
 
RSA Biomedical is a worldwide provider of high-precision products and measurement systems in digital medical imaging. Hundreds of hospitals, clinicians, medical researchers, and medical device manufacturers in North America, Europe, Australia, and Asia use the RSA method.
 
“RSA Biomedical clearly understands what is needed to bring an orthopaedic implant into clinical practice. Its support of the move toward CT-based measurements represents an important step forward in efforts to make this type of validation the new gold standard. I’m excited about what our collaboration will lead to in terms of increased availability of safer orthopaedic implants and ultimately, improved patient outcomes,” said Gustaf Schwang, general manager, Business Unit Orthopaedic Solutions, at Sectra, an international medical imaging IT and cybersecurity company.
 
Sectra CTMA is part of the orthopedic module of Sectra’s enterprise imaging solution. The enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. 
 
Sectra CTMA is a registered trademark of Sectra AB and is patent pending.